Vanessa Tran

InstitutionPublic Health Ontario
AddressToronto
Ontario
Canada
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 7 Covid-19 publications, with a maximum of 2 publications in April 2021
    All Publications
    Bar chart showing 25 publications over 10 distinct years, with a maximum of 7 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Gubbay JB, Rilkoff H, Kristjanson HL, Forbes JD, Murti M, Eshaghi A, Broukhanski G, Corbeil A, Fittipaldi N, Hopkins JP, Kristjanson E, Kus JV, Macdonald L, Majury A, Mallo GV, Mazzulli T, Melano RG, Olsha R, Perusini SJ, Tran V, Allen VG, Patel SN. Impact of coronavirus disease 2019 (COVID-19) pre-test probability on positive predictive value of high cycle threshold severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcription polymerase chain reaction (RT-PCR) test results. Infect Control Hosp Epidemiol. 2021 Aug 09; 1-5. PMID: 34369325.
      Citations:    Fields:    
    2. Guthrie JL, Chen AJ, Budhram DR, Cronin K, Peci A, Nelson P, Mallo GV, Broukhanski G, Murti M, Majury A, Mazzulli T, Allen VG, Patel SN, Kus JV, Tran V, Gubbay JB. Characteristics of SARS-CoV-2 testing for rapid diagnosis of COVID-19 during the initial stages of a global pandemic. PLoS One. 2021; 16(7):e0253941. PMID: 34242243.
      Citations:    Fields:    Translation:HumansPHPublic Health
    3. Zhang Y, Malekjahani A, Udugama BN, Kadhiresan P, Chen H, Osborne M, Franz M, Kucera M, Plenderleith S, Yip L, Bader GD, Tran V, Gubbay JB, McGeer A, Mubareka S, Chan WCW. Surveilling and Tracking COVID-19 Patients Using a Portable Quantum Dot Smartphone Device. Nano Lett. 2021 06 23; 21(12):5209-5216. PMID: 34110166.
      Citations:    Fields:    Translation:Humans
    4. Charlton C, Kanji J, Tran V, Kus J, Gubbay J, Osiowy C, Robinson J, Sekirov I, Drebot M, Hatchette T, Stein D, El-Gabalawy N, Lang A, Jiao L, Levett P, Wood H, Therrien C, Lindsay LR, Morshed M, Forbes J, Dibernardo A. Practical guidance for clinical laboratories for SARS-CoV-2 serology testing. Can Commun Dis Rep. 2021 May 07; 47(4):171-183. PMID: 34035663.
      Citations: 3     Fields:    
    5. Stein DR, Osiowy C, Gretchen A, Thorlacius L, Fudge D, Lang A, Sekirov I, Morshed M, Levett PN, Tran V, Kus JV, Gubbay J, Mohan V, Charlton C, Kanji JN, Tipples G, Serhir B, Therrien C, Roger M, Jiao L, Zahariadis G, Needle R, Gilbert L, Desnoyers G, Garceau R, Bouhtiauy I, Longtin J, El-Gabalawy N, Dibernardo A, Lindsay LR, Drebot M. Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratories. Diagn Microbiol Infect Dis. 2021 Nov; 101(3):115412. PMID: 34425450.
      Citations:    Fields:    Translation:HumansPHPublic Health
    6. Bolotin S, Tran V, Osman S, Brown KA, Buchan SA, Joh E, Deeks SL, Allen VG. SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline. J Infect Dis. 2021 04 23; 223(8):1334-1338. PMID: 33400794.
      Citations: 9     Fields:    Translation:Humans
    7. Peci A, Tran V, Guthrie JL, Li Y, Nelson P, Schwartz KL, Eshaghi A, Buchan SA, Gubbay JB. Prevalence of Co-Infections with Respiratory Viruses in Individuals Investigated for SARS-CoV-2 in Ontario, Canada. Viruses. 2021 Jan 18; 13(1). PMID: 33477649.
      Citations: 10     Fields:    Translation:Humans